ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,077Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 2604

$629K Total Retail Price of All Prescriptions

Rank: 105 out of 2604

469 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 406 346 1 4
SIMVASTATIN 356 274 2 2
LISINOPRIL 349 309 3 3
FUROSEMIDE 336 304 4 8
HYDROCODONE-ACETAMINOPHEN 330 203 S3 5 1
METOPROLOL TARTRATE 201 177 6 9
OMEPRAZOLE 172 127 7 5
AMLODIPINE BESYLATE 164 141 8 6
POTASSIUM CHLORIDE 154 123 9 16
METFORMIN HCL 141 99 10 7
TRAMADOL HCL 141 135 10 15
ATENOLOL 138 112 12 11
WARFARIN SODIUM 133 104 13 13
CITALOPRAM HBR 130 103 14 18
ISOSORBIDE MONONITRATE ER 128 88 15 38
METOPROLOL SUCCINATE 122 84 16 17
TAMSULOSIN HCL 116 83 17 30
GABAPENTIN 113 76 18 12
SERTRALINE HCL 112 96 19 23
DONEPEZIL HCL 111 103 20 28
QUETIAPINE FUMARATE 108 72 21 66
SPIRIVA 106 88 22 45
CIPROFLOXACIN HCL 105 76 23 59
NAMENDA 97 97 24 37
MIRTAZAPINE 96 84 25 52
CLOPIDOGREL 95 83 26 39
PREDNISONE 86 69 27 34
PLAVIX 82 74 28 75
CARVEDILOL 82 75 28 26
RISPERIDONE 80 67 30 65
MELOXICAM 76 61 31 36
AZITHROMYCIN 74 59 32 33
FENOFIBRATE 73 40 33 69
ALENDRONATE SODIUM 72 59 34 29
IBUPROFEN 72 52 34 32
ADVAIR DISKUS 71 63 36 41
ENALAPRIL MALEATE 66 43 37 50
OXYCODONE HCL-ACETAMINOPHEN 65 28 S2 38 106
RANITIDINE HCL 64 47 39 25
PANTOPRAZOLE SODIUM 60 56 40 64
HYDROCHLOROTHIAZIDE 59 51 41 10
ALBUTEROL SULFATE 57 57 42 93
LOSARTAN POTASSIUM 57 56 42 20
CYCLOBENZAPRINE HCL 56 0 R 44 43
HYDROXYZINE HCL 56 53 R 44 214
IPRATROPIUM BROMIDE 55 55 46 164
SYNTHROID 55 55 46 127
ESCITALOPRAM OXALATE 55 47 46 73
GLIMEPIRIDE 53 28 49 57
FINASTERIDE 53 41 49 103
PAROXETINE HCL 52 49 51 62
TRAZODONE HCL 51 17 52 46
POLYETHYLENE GLYCOL 3350 50 49 53 42
PRAVASTATIN SODIUM 50 47 53 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.